{
    "2018-10-30": [
        [
            {
                "time": "2018-10-30",
                "original_text": "After Hours Most Active for Oct 30, 2018: PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Most Active",
                        "PX",
                        "FB",
                        "QQQ",
                        "FDC",
                        "XOG",
                        "MS",
                        "F",
                        "PFE",
                        "MFGP",
                        "ERIC",
                        "EGRX",
                        "EBAY"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Is Beaten-Down Celgene Corporation a Buy Now?",
                "features": {
                    "keywords": [
                        "Beaten-Down",
                        "Celgene Corporation",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "3M",
                        "Buy",
                        "Q3 2018 Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/30/2018",
                "features": {
                    "keywords": [
                        "Validea",
                        "Joel Greenblatt",
                        "Strategy",
                        "Daily Upgrade Report"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}